Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Indena’s Meriva Awarded “Best New Product” | Contract Pharma
Breaking News

Indena’s Meriva Awarded “Best New Product”

Indena’s Meriva has been awarded “Best New Product” of the year by a European outsourcing panel.

Indena’s Meriva has been awarded “Best New Product” of the year by a European outsourcing panel. The award is presented to companies that have developed a product that, through excellence in research, development and/or manufacturing, has resulted in the launch of a new offering in the pharma/biopharma sector that demonstrates substantial benefits to patient populations compared to existing therapeutics for that disease condition.

Meriva is complex of curcumin (Curcuma longa L.) that uses the basic principles of the Phytosome strategy to improve bioavailability. Recent studies have demonstrated a 20-fold enhanced bioavailability of Meriva compared to a standardized curcumin extract. Also, a recent long-term clinical study has demonstrated safety and efficacy in the treatment of inflammatory diseases.

“We’re very pleased to receive this award,” said Christian Artaria, Indena marketing director and head of functional food development at Indena. “Indena’s model of identifying research and industrial collaborations ranging from R&D Institutions to hospitals and private clinics early in the product development cycle has again proven effective in shortening the time to market with this exciting product.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters